Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by —NR.sup.a.sub.2, —OR.sup.a, —SR.sup.a, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by —OR.sup.a, —SR.sup.a, —COOR.sup.a, —COR.sup.a, —SO.sub.2R.sup.a, or —SO.sub.3R.sup.a. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by —NR.sup.b.sub.2, —OR.sup.b, or —SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by —SR.sup.b. ##STR00001##

Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by —NR.sup.a.sub.2, —OR.sup.a, —SR.sup.a, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by —OR.sup.a, —SR.sup.a, —COOR.sup.a, —COR.sup.a, —SO.sub.2R.sup.a, or —SO.sub.3R.sup.a. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by —NR.sup.b.sub.2, —OR.sup.b, or —SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by —SR.sup.b. ##STR00001##

The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, hypercholesterolemia.

##STR00001##

The present invention discloses an amino lipid compound, a preparation method and use of the same. The present invention also provides lipid particles comprising the amino lipid compound, and use thereof for delivering bioactive agents into cells. The present invention also provides a use of lipid particles comprising the amino lipid as a medicament.

The present invention discloses an amino lipid compound, a preparation method and use of the same. The present invention also provides lipid particles comprising the amino lipid compound, and use thereof for delivering bioactive agents into cells. The present invention also provides a use of lipid particles comprising the amino lipid as a medicament.

Trisubstituted triazines having the formula: ##STR00001## wherein: X is O and n is 0 or 1, Y is OH, NH.sub.2 or CH.sub.2NH.sub.2, Q is P, P═O, CH or N, when Q is P, R is phenyl, when Q is P═O, Z is R or OR, and R is alkyl or phenyl, when Q is CH, Z is PO(R).sub.2 or PO(OR).sub.2, when Q is N, Z is R, and their uses as epoxy and cyclic carbonate polymer curing agents.

Trisubstituted triazines having the formula: ##STR00001## wherein: X is O and n is 0 or 1, Y is OH, NH.sub.2 or CH.sub.2NH.sub.2, Q is P, P═O, CH or N, when Q is P, R is phenyl, when Q is P═O, Z is R or OR, and R is alkyl or phenyl, when Q is CH, Z is PO(R).sub.2 or PO(OR).sub.2, when Q is N, Z is R, and their uses as epoxy and cyclic carbonate polymer curing agents.

The present invention provides novel compounds having a P2X.sub.3 and/or P2X.sub.2/3 receptor antagonistic effect. A pharmaceutical composition having an analgesic effect or an improving effect of urination disorder comprising a compound of the formula (I): ##STR00001##
wherein
R.sup.h and R.sup.i are taken together to form a bond; R.sup.a and R.sup.b and/or R.sup.d and R.sup.e are taken together to form oxo or the like; R.sup.c is hydrogen, substituted or unsubstituted alkyl or the like;
R.sup.f is —(CR.sup.4aR.sup.4b).sub.n—R.sup.2; R.sup.4a and R.sup.4b are hydrogen, substituted or unsubstituted alkyl or the like; R.sup.2 is substituted or unsubstjtuted cycloalkyl or the like; n is an integer of 1 to 4; —R.sup.g is —X—R.sup.3; —X— is —O—, —S— or the like; R.sup.3 is substituted or unsubstituted cycloalkyl or the like,
or its pharmaceutically acceptable salt or a solvate thereof.

The present invention provides novel compounds having a P2X.sub.3 and/or P2X.sub.2/3 receptor antagonistic effect. A pharmaceutical composition having an analgesic effect or an improving effect of urination disorder comprising a compound of the formula (I): ##STR00001##
wherein
R.sup.h and R.sup.i are taken together to form a bond; R.sup.a and R.sup.b and/or R.sup.d and R.sup.e are taken together to form oxo or the like; R.sup.c is hydrogen, substituted or unsubstituted alkyl or the like;
R.sup.f is —(CR.sup.4aR.sup.4b).sub.n—R.sup.2; R.sup.4a and R.sup.4b are hydrogen, substituted or unsubstituted alkyl or the like; R.sup.2 is substituted or unsubstjtuted cycloalkyl or the like; n is an integer of 1 to 4; —R.sup.g is —X—R.sup.3; —X— is —O—, —S— or the like; R.sup.3 is substituted or unsubstituted cycloalkyl or the like,
or its pharmaceutically acceptable salt or a solvate thereof.

Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by —NR.sup.a.sub.2, —OR.sup.a, —SR.sup.a, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by —OR.sup.a, —SR.sup.a, —COOR.sup.a, —COR.sup.a, —SO.sub.2R.sup.a, or —SO.sub.3R.sup.a. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by —NR.sup.b.sub.2, —OR.sup.b, or —SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by —SR.sup.b.

##STR00001##